Hypoxia-inducible factor (HIF)/vascular endothelial growth factor (VEGF) signaling in the retina

Advances in Experimental Medicine and Biology

Volumn 801, Issue , 2014, Pages 275-281

  Kurihara, Toshihide ^a   Westenskow, Peter D ^a   Friedlander, Martin ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Age related macular degeneration; Hypoxia inducible factors; Retinal pigment epithelium; Vascular endothelial growth factor; Von Hippel Lindau tumor suppressor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 2ALPHA; VASCULOTROPIN; ARNT PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGE RELATED MACULAR DEGENERATION; ARTICLE; DEVELOPMENTAL STAGE; HUMAN; MOLECULAR CLONING; NONHUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA DISEASE; RETINOPATHY; RETROLENTAL FIBROPLASIA; SIGNAL TRANSDUCTION; SUBRETINAL NEOVASCULARIZATION; METABOLISM; PATHOLOGY; RETINA MACULA DEGENERATION; REVIEW;

ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MACULAR DEGENERATION; RETINAL PIGMENT EPITHELIUM; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84904812095     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3209-8_35     Document Type: Article

References (40)

1. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331(22):1480-1487
2. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351(27):2805-2816
3. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355(14):1419-1431
4. Stewart MW, Grippon S, Kirkpatrick P (2012) Aflibercept. Nat Rev Drug Discov 11(4):269- 270
5. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS et al (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380(6573):439-442
6. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M et al (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380(6573):435-439
7. Eremina V, Jefferson JA, Kowalewska J, Hochster H, Haas M, Weisstuch J et al (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358(11):1129-1136
8. Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC et al (2008) VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma. J Exp Med 205(2):491-501
9. Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A et al (2006) Paclitaxelcarboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355(24):2542-2550
10. Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE et al (2012) Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology 119(7):1388-1398
11. Kurihara T, Westenskow PD, Bravo S, Aguilar E, Friedlander M (2012) Targeted deletion of Vegfa in adult mice induces vision loss. J Clin Invest 122(11):4213-4217
12. Semenza GL, Wang GL (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 12(12):5447-5454
13. Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basichelix- loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92(12):5510-5514
14. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399(6733):271-275
15. Ito M, Yoshioka M (1999) Regression of the hyaloid vessels and pupillary membrane of the mouse. Anat Embryol (Berl) 200(4):403-411
16. Kurihara T, Westenskow PD, Krohne TU, Aguilar E, Johnson RS, Friedlander M (2011) Astrocyte pVHL and HIF-alpha isoforms are required for embryonic-to-adult vascular transition in the eye. J Cell Biol 195(4):689-701
17. Dorrell MI, Aguilar E, Friedlander M (2002) Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. Invest Ophthalmol Vis Sci 43(11):3500-3510
18. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A et al (2003) VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 161(6):1163-1177
19. Yu DY, Cringle SJ (2001) Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res 20(2):175-208
20. Kurihara T, Kubota Y, Ozawa Y, Takubo K, Noda K, Simon MC et al (2010) von Hippel- Lindau protein regulates transition from the fetal to the adult circulatory system in retina. Development 137(9):1563-1571
21. Weidemann A, Krohne TU, Aguilar E, Kurihara T, Takeda N, Dorrell MI et al (2010) Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina. Glia 58(10):1177-1185
22. Scott A, Powner MB, Gandhi P, Clarkin C, Gutmann DH, Johnson RS et al (2010) Astrocytederived vascular endothelial growth factor stabilizes vessels in the developing retinal vasculature. PLoS One 5(7):e11863
23. Nakamura-Ishizu A, Kurihara T, Okuno Y, Ozawa Y, Kishi K, Goda N et al (2012) The formation of an angiogenic astrocyte template is regulated by the neuroretina in a HIF-1-dependent manner. Dev Biol 363(1):106-114
24. Caprara C, Thiersch M, Lange C, Joly S, Samardzija M, Grimm C (2011) HIF1A is essential for the development of the intermediate plexus of the retinal vasculature. Invest Ophthalmol Vis Sci 52(5):2109-2117
25. Marneros AG, Fan J, Yokoyama Y, Gerber HP, Ferrara N, Crouch RK et al (2005) Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol 167(5):1451-1459
26. Le YZ, Bai Y, Zhu M, Zheng L (2010) Temporal requirement of RPE-derived VEGF in the development of choroidal vasculature. J Neurochem 112(6):1584-1592
27. Lin M, Hu Y, Chen Y, Zhou KK, Jin J, Zhu M et al (2012) Impacts of hypoxia-inducible factor-1 knockout in the retinal pigment epithelium on choroidal neovascularization. Invest Ophthalmol Vis Sci 53(10):6197-6206
28. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D'Amore PA (2009) An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci U S A 106(44):18751-18756
29. Robinson GS, Ju M, Shih SC, Xu X, McMahon G, Caldwell RB et al (2001) Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development. Faseb J 15(7):1215-1217
30. Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, Jo N et al (2007) Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 171(1):53-67
31. Saint-Geniez M, Maharaj AS, Walshe TE, Tucker BA, Sekiyama E, Kurihara T et al (2008) Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS One 3(11):e3554
32. Arany Z, Foo SY, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G et al (2008) HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha. Nature 451(7181):1008-1012
33. Schmidt D, Textor B, Pein OT, Licht AH, Andrecht S, Sator-Schmitt M et al (2007) Critical role for NF-kappaB-induced JunB in VEGF regulation and tumor angiogenesis. Embo J 26(3):710-719
34. Lange CA, Luhmann UF, Mowat FM, Georgiadis A, West EL, Abrahams S et al (2012) Von Hippel-Lindau protein in the RPE is essential for normal ocular growth and vascular development. Development 139(13):2340-2350
35. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R et al (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35(1):101-111
36. Ozaki H, Yu AY, Della N, Ozaki K, Luna JD, Yamada H et al (1999) Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci 40(1):182-189
37. Mowat FM, Luhmann UF, Smith AJ, Lange C, Duran Y, Harten S et al (2010) HIF-1alpha and HIF-2alpha are differentially activated in distinct cell populations in retinal ischaemia. PLoS One 5(6):e11103
38. Morita M, Ohneda O, Yamashita T, Takahashi S, Suzuki N, Nakajima O et al (2003) HLF/ HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. Embo J 22(5):1134-1146
39. Poulaki V, Qin W, Joussen AM, Hurlbut P, Wiegand SJ, Rudge J et al (2002) Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. J Clin Invest 109(6):805-815
40. Ryan SJ (1979) The development of an experimental model of subretinal neovascularization in disciform macular degeneration. Trans Am Ophthalmol Soc 77:707-745